Dry eye disease presents differently across patients, making subtype-based treatment essential for effective management. In this video, experts discuss dry eye subtypes and evaluate whether Lifitegrast (Lifanta) is the right therapeutic fit for ocular surface inflammation.
Key highlights include:
Understanding inflammatory dry eye and mixed subtypes Clinical considerations for selecting Lifitegrast Practical insights from real-world practice A concise, clinically relevant discussion for ophthalmologists and eye care professionals.
By : Dr. Eric Donnenfled
Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.